SKLB 610

SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR.

1125780-41-7

≥ 2 years

>98% (HPLC)

415.37

C21H16F3N3O3

Research use only, not for human use.

FGFR| PDGFR| VEGFR

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

326727 5.0mg

Ask

RC221669L4 10 µg

Ask

KMPH6473 20 µg

Ask

GTR15174960 1 Vial

Ask

TA346082 100 µL

Ask